A Case of GLP-1 Receptor Agonist-Induced Lithium Neurotoxicity
Anuhya Kotta, Sahar Ashraf, Mehreen Khan, Dustin DeMoss et autres
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are a hoped-for intervention to reduce nonadherence to psychotropic medications due to metabolic syndrome and, potentially, to reduce metabolic syndrome-related premature cardiovascular death among those undergoing treatment for bipolar disorder. GLP-1 RAs are currently approved by …
us, sg (code pays fourni par la source)